Biotech

All Articles

Novo inks $600M NanoVation deal to research hereditary drugs ex-liver

.Novo Nordisk is actually proceeding its press into hereditary medicines, agreeing to compensate Nan...

Innovent links cytokine to colon cancer cells responses

.Innovent Biologics has produced the situation that its own gate inhibitor-cytokine fusion protein h...

Merck, Daiichi ADC attacks goal in phase 3 lung cancer cells research study

.A stage 3 trial of Daiichi Sankyo and Merck &amp Co.'s HER3-directed antibody-drug conjugate (ADC) ...

Rakovina strengthens AI center along with collab to decide on cancer cells aim ats

.5 months after Rakovina Therapeutics turned toward expert system, the cancer-focused biotech has ac...

Ascendis' dwarfism drug smash hits in stage 3, threatens BioMarin

.Ascendis Pharma has become a prospective hazard to BioMarin's Voxzogo, mentioning phase 3 developme...

Despite ph. 3 skip, Alkeus observes course ahead for eye illness resource

.Though Alkeus Pharmaceuticals' oral eye health condition resource failed to dramatically lessen geo...

Kairos goes public along with $6M IPO to money trials of cancer cells medicine

.Along with a triad of biotechs attacking the Nasdaq on Friday, it was easy to miss a smaller-scale ...

Vaccine and also Keytruda combo successful in squamous tissue carcinoma

.Immune system checkpoint preventions are the superheroes of cancer cells therapy. Medications like ...

Cue Biopharma queues up J&ampJ veterinarian as CBO-- Chutes &amp Ladders

.Welcome to today's Chutes &amp Ladders, our summary of substantial leadership hirings, shootings an...

Regeneron's Opdualag competitor reveals 57% response cost

.Regeneron is back with lasting consequence for its own LAG-3 inhibitor and PD-1 prevention combo in...